Biotech
Colossal Biosciences
Colossal Biosciences raises $120M Series at $800M valuation
$120M
Total Raised
Series
Latest Round
2021
Founded
100+
Employees
Austin, TX
1 min read
Quick Facts
Valuation
$800M
Latest Round Size
$120M
Latest Round Date
September 2025
Colossal Biosciences: Series Funding Round
Colossal Biosciences has successfully raised $120M in Series funding, reaching a valuation of $800M.
Company Overview
Working on de-extinction of species including mammoths and dodos
Funding Details
The Series round was led by CIA In-Q-Tel, with participation from Breyer Capital.
Company Information
- Headquarters: Austin, TX
- Founded: 2021
- Employees: 100+
- Category: Biotech
Investment
Colossal Biosciences plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- CIA In-Q-Tel: Verified investor in Series
- Breyer Capital: Verified investor in Series
Key Investors
CIA In-Q-Tel
Lead Investor
Verified investor in Series
Breyer Capital
Investor
Verified investor in Series
About the Author
Editorial Team
Curated funding news from verified sources
Related Company Reports
Biotech
Orna Therapeutics
Orna Therapeutics Raises $251M Series B
Biotechnology company developing circular RNA therapeutics for cancer, genetic diseases, and infectious diseases
Emma Rodriguez
Oct 23, 2025
0 min read•$251M Series B
Biotech
Forge Biologics
Forge Biologics Raises $120M Series C
Gene therapy CDMO providing manufacturing and development services for AAV-based genetic medicines
Sarah Kim
Oct 23, 2025
0 min read•$120M Series C
Biotech
Vir Biotechnology
Vir Biotechnology Raises $250M
Clinical-stage immunology company developing treatments for infectious diseases including COVID-19, hepatitis B, and influenza
Sarah Kim
Oct 23, 2025
0 min read•$250M